VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

KIMSHEALTH Cancer Centre achieves success with complex haploidentical stem cell transplant, showcasing advanced expertise in bone marrow procedures.

A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin ...

As of 2021, 1.7 million adults in the United States were living with type 1 diabetes, according to statistics from the CDC.

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

Vertex Pharmaceuticals may have narrowed its focus this year, but the biopharma’s decision to stick with its remaining islet ...

While BMO Capital Markets said that zimislecel is “highly encouraging” for type 1 diabetes, questions regarding its target ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

Stockholder-approved financing brings total gross proceeds to $7.1 million; funds to support working capital ...

Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...